RCEL

Avita Medical INC

+$199.2M

Net Activity

Institutions Holding

79

Popularity Rank

#4983

Avg Weight

0.05%

Total Value

$216.1M

Ownership Trend

79 institutions currently hold RCEL, with 51 net buyers and 27 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

27

Net Buying Institutions

51

Key Holders

View all 79 holding institutions

Quarterly Activity

Recent Activity

+$208.2M

Total Buy Value

$2.4M

Total Sell Value

New buy24
Trim13
Add27
Sold out14

51

Net Buyers

27

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AVITA MEDICAL INC (RCEL)?
Major stakeholders currently include Orbimed Advisors LLC ($197.0M), Vanguard Capital Management LLC ($4.9M), BlackRock, Inc. ($4.2M). Based on the latest 13F filings, there are a total of 79 tracked investment funds and institutions maintaining positions in RCEL.
What is the overall institutional sentiment toward RCEL recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $199.2M, driven by 51 managers accumulating shares while 27 reduced their exposure.
Which institutions have been selling or reducing their RCEL positions?
In the latest period, 13 funds trimmed their holdings, and 14 managers completely exited their positions. The aggregate reported sell value was $2.4M.
Are there any notable investors adding RCEL to their portfolios?
Yes, buying activity remains notable. 24 institutions opened new positions in {ticker}, and 27 existing holders added to their shares. The total reported buy value for the quarter amounted to $208.2M.

Related Stocks